[1]
J. Żołnierek and P. Wysocki, “Quality of life in oncology in course of molecularly targeted therapy in patients diagnosed with metastatic renal-cell carcinoma”, OncoReview, vol. 1, no. 4(4), pp. 293-303, Dec. 2011.